Logo

American Heart Association

  23
  0


Final ID: Mo4090

Clinical Relevance of FFR-guided PCI According to Left Ventricular Systolic Function in Patients with Acute Myocardial Infarction and Multivessel Disease

Abstract Body (Do not enter title and authors here): Background: Fractional flow reserve (FFR) or angiography-guided complete revascularization was not evaluated in patients with acute myocardial infarction (MI) with reduced left ventricular ejection fraction (LVEF).
Objectives: To evaluate impact of FFR-guided percutaneous coronary intervention (PCI) for AMI patients with multivessel disease according to left ventricular systolic function.
Methods: We performed pre-specified analysis of FRAME-AMI trial which randomly allocated 562 patients into either FFR-guided PCI (FFR≤0.80) or angiography-guided PCI (diameter stenosis of >50%) for non-infarct related artery (IRA). Patients were classified by LVEF into the preserved (LVEF ≥50%) and reduced (LVEF <50%) groups. The primary end point was patient-oriented composite outcome (POCO), a composite of death, MI, and repeat revascularization.
Results: Overall, 187 patients (33.3%) had reduced LVEF. At 4-year follow-up, AMI patients with reduced LVEF showed increased risk of MACE than those with preserved LVEF (18.9% vs. 10.8%; adjusted HR=2.65, 95% CI 1.53-4.58, P<0.001). FFR-guided PCI for non-IRA significantly reduced POCO among preserved LVEF group (3.3% vs. 19.0%; adjusted HR=0.23, 95% CI 0.09-0.59, P=0.002). Conversely, there was no significant difference in POCO between FFR and angiography-guided PCI among reduced LVEF group (17.0% vs. 21.0%; HR=0.64, 95% CI 0.31-1.32, P=0.227). The prognostic impact of FFR-guided PCI tended to increase as LVEF increased (adjusted HR for POCO: 0.69 vs. 0.66 vs. 0.25 vs. 0.20, respectively, for the LVEF ≤40% vs. 40-50% vs. 50-60% vs. ≥60%, interaction P=0.028).
Conclusion: In acute MI patients with multivessel disease, FFR-guided PCI for non-IRA showed differential clinical impact according to left ventricular systolic function. The beneficial effect of FFR-guided PCI might be maximized among patients with preserved LVEF rather than reduced LVEF.
  • Lee, Yong-kyu  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Hahn, Joo-yong  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Kim, Hyun Kuk  ( Chosun University Hospital , Gwangju , Korea (the Republic of) )
  • Park, Keun Ho  ( Chosun University Hospital , Gwangju , Korea (the Republic of) )
  • Choo, Eun Ho  ( Seoul St. Mary’s Hospital , Seoul , Korea (the Republic of) )
  • Kim, Chan Joon  ( Uijungbu St. Mary's Hospital , Uijungbu , Korea (the Republic of) )
  • Ahn, Gyun  ( Wonju Severance Christian Hospital , Wonju , Korea (the Republic of) )
  • Doh, Joon-hyung  ( Inje University Ilsan Paik Hospital , Goyang , Korea (the Republic of) )
  • Lee, Sang Yeub  ( Chung-Ang University Gwangmyeong Hospital , Gwangmyeong , Korea (the Republic of) )
  • Park, Sang Don  ( Inha University Hospital , Incheon , Korea (the Republic of) )
  • Lee, Hyun-jong  ( Sejong General Hospital , Bucheon , Korea (the Republic of) )
  • Lee, Seung Hun  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Kang, Min Gyu  ( Gyeongsang National University Hospital , Jinju , Korea (the Republic of) )
  • Nam, Chang-wook  ( Keimyung University Dongsan Hospital , Daegu , Korea (the Republic of) )
  • Choi, Ki Hong  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Park, Taek Kyu  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Yang, Jeong Hoon  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Song, Young Bin  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Choi, Seung-hyuk  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Kim, Ju Han  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Ahn, Youngkeun  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Jeong, Myung Ho  ( Gwangju Veterans Hospital , Gwangju , Korea (the Republic of) )
  • Kim, Hangyul  ( Gyeongsang National University Hospital , Jinju , Korea (the Republic of) )
  • Gwon, Hyeon-cheol  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Koh, Jin-sin  ( Gyeongsang National University Hospital , Jinju , Korea (the Republic of) )
  • Hong, Young Joon  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Ahn, Joon Ho  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Cho, Kyung Hoon  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Kim, Min Chul  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Sim, Doo Sun  ( Chonnam National University Hospital , Gwangju , Korea (the Republic of) )
  • Lee, Joo Myung  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Hong, David  ( Samsung Medical Center , Seoul , Korea (the Republic of) )
  • Author Disclosures:
    Yong-Kyu Lee: DO NOT have relevant financial relationships | Joo-Yong Hahn: No Answer | Hyun Kuk Kim: DO NOT have relevant financial relationships | Keun Ho Park: No Answer | Eun Ho Choo: No Answer | Chan Joon Kim: No Answer | Gyun Ahn: No Answer | Joon-Hyung Doh: No Answer | Sang Yeub Lee: No Answer | Sang Don Park: No Answer | Hyun-Jong Lee: No Answer | Seung Hun Lee: DO NOT have relevant financial relationships | Min Gyu Kang: DO NOT have relevant financial relationships | Chang-Wook Nam: No Answer | Ki Hong Choi: No Answer | Taek Kyu Park: No Answer | Jeong Hoon Yang: DO NOT have relevant financial relationships | Young Bin Song: DO NOT have relevant financial relationships | Seung-Hyuk Choi: No Answer | Ju Han Kim: No Answer | Youngkeun Ahn: DO NOT have relevant financial relationships | Myung Ho Jeong: No Answer | Hangyul Kim: No Answer | Hyeon-Cheol Gwon: No Answer | Jin-sin Koh: DO NOT have relevant financial relationships | Young Joon Hong: No Answer | Joon Ho Ahn: No Answer | Kyung Hoon Cho: DO have relevant financial relationships ; Researcher:Amgen:Past (completed) ; Speaker:Viatris:Past (completed) ; Speaker:Sanofi:Past (completed) ; Speaker:Amgen:Past (completed) | Min Chul Kim: DO NOT have relevant financial relationships | Doo Sun Sim: No Answer | Joo Myung Lee: No Answer | David Hong: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

What's Hot in Percutaneous Coronary Intervention?

Monday, 11/18/2024 , 01:30PM - 02:30PM

Abstract Poster Session

More abstracts on this topic:
Dual inhibition of PDE5-mTOR Enhances Chemoimmunotherapeutic Efficacy in Breast Cancer and Reduces Cardiotoxicity

Das Anindita, Mathew Rebecca, Kodali Varun, Zwiren Virginia, Kraskauskas Donatas, Somasundaram Krishal, Kukreja Rakesh

Abbreviated Ticagrelor-Based Dual Antiplatelet Therapy in Acute Coronary Syndrome: A Systematic Review and Meta-Analysis

Harmouch Wissam, Elbadawi Ayman, Thakker Ravi, Khalid Umair, Khalife Wissam, Kleiman Neal, Rangasetty Umamahesh, Kayani Waleed, Jneid Hani, Al Hemyari Bashar

More abstracts from these authors:
Long-Term Clinical Outcomes in Definite versus Intermediate Ergovonine Provocation response in Multivessel Vasospastic Angina Patients

Joo Donghyeon, Lim Yongwhan, Oh Seok, Lee Yong-kyu, Park Seong Ho, Ahn Youngkeun, Kim Ju Han, Sim Doo Sun, Hong Young Joon, Cho Kyung Hoon, Ahn Joon Ho, Lee Seung Hun, Hyun Dae Young

Impact of Non-Culprit Chronic Total Occlusion in Patients with Infarct-Related Cardiogenic Shock: Results from the RESCUE Registry

Kim Min Chul, Kwon Sung Uk, Lee Wang Soo, Jeong Jin-ok, Park Sang-don, Lim Seong-hoon, Ahn Youngkeun, Choi Ki Hong, Yang Jeong Hoon, Gwon Hyeon-cheol, Ahn Chul-min, Yu Cheolwoong, Chun Woojung, Bae Jang-whan

You have to be authorized to contact abstract author. Please, Login
Not Available